India is prioritising the supply of a potential coronavirus drug to its own people by banning exports, as other countries, hospitals and even individual doctors join the global grab for an unproven treatment hailed by US President Donald Trump as a game-changer.
The world’s largest exporter of generic drugs, India has recommended that its healthcare workers and high-risk individuals use the antimalarial drug hydroxychloroquine to try to prevent Covid-19 infections.
There has been a surge in global demand for both hydroxychloroquine and chloroquine, a similar drug with greater side effects, despite a lack of solid scientific evidence that they work against the novel coronavirus.
您已阅读17%（686字），剩余83%（3309字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。